Literature DB >> 24636868

3D cell culture systems modeling tumor growth determinants in cancer target discovery.

Claudio R Thoma1, Miriam Zimmermann2, Irina Agarkova3, Jens M Kelm3, Wilhelm Krek4.   

Abstract

Phenotypic heterogeneity of cancer cells, cell biological context, heterotypic crosstalk and the microenvironment are key determinants of the multistep process of tumor development. They sign responsible, to a significant extent, for the limited response and resistance of cancer cells to molecular-targeted therapies. Better functional knowledge of the complex intra- and intercellular signaling circuits underlying communication between the different cell types populating a tumor tissue and of the systemic and local factors that shape the tumor microenvironment is therefore imperative. Sophisticated 3D multicellular tumor spheroid (MCTS) systems provide an emerging tool to model the phenotypic and cellular heterogeneity as well as microenvironmental aspects of in vivo tumor growth. In this review we discuss the cellular, chemical and physical factors contributing to zonation and cellular crosstalk within tumor masses. On this basis, we further describe 3D cell culture technologies for growth of MCTS as advanced tools for exploring molecular tumor growth determinants and facilitating drug discovery efforts. We conclude with a synopsis on technological aspects for on-line analysis and post-processing of 3D MCTS models.
Copyright © 2014 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  3D cell culture; Cancer cell signaling; Cisplatin (PubChem CID: 441203); Crizotinib (PubChem CID: 11626560); Doxorubicin (PubChem CID: 31703); Ethylene glycol (PubChem CID: 174); Imatinib (PubChem CID: 5291); Molecular cancer targets; Multicellular tumor spheroid (MCTS); Nitric oxide (PubChem CID: 145068); Oxygen (PubChem CID: 977); Pimonidazole (PubChem CID: 50981); Screening technology; Tumor microenvironment; Vemurafenib (PubChem CID: 42611257); ε-Caprolactone (PubChem CID: 10401)

Mesh:

Substances:

Year:  2014        PMID: 24636868     DOI: 10.1016/j.addr.2014.03.001

Source DB:  PubMed          Journal:  Adv Drug Deliv Rev        ISSN: 0169-409X            Impact factor:   15.470


  139 in total

1.  Transitions from mono- to co- to tri-culture uniquely affect gene expression in breast cancer, stromal, and immune compartments.

Authors:  Mary C Regier; Lindsey J Maccoux; Emma M Weinberger; Keil J Regehr; Scott M Berry; David J Beebe; Elaine T Alarid
Journal:  Biomed Microdevices       Date:  2016-08       Impact factor: 2.838

Review 2.  Human Colon Organoids and Other Laboratory Strategies to Enhance Patient Treatment Selection.

Authors:  Katherine A Johnson; Rebecca A DeStefanis; Philip B Emmerich; Patrick T Grogan; Jeremy D Kratz; Sarbjeet K Makkar; Linda Clipson; Dustin A Deming
Journal:  Curr Treat Options Oncol       Date:  2020-04-23

3.  Cytotoxic responses of carnosic acid and doxorubicin on breast cancer cells in butterfly-shaped microchips in comparison to 2D and 3D culture.

Authors:  Ece Yildiz-Ozturk; Sultan Gulce-Iz; Muge Anil; Ozlem Yesil-Celiktas
Journal:  Cytotechnology       Date:  2017-02-13       Impact factor: 2.058

4.  Metabolite profiling and pharmacokinetic evaluation of hydrocortisone in a perfused three-dimensional human liver bioreactor.

Authors:  Ujjal Sarkar; Dinelia Rivera-Burgos; Emma M Large; David J Hughes; Kodihalli C Ravindra; Rachel L Dyer; Mohammad R Ebrahimkhani; John S Wishnok; Linda G Griffith; Steven R Tannenbaum
Journal:  Drug Metab Dispos       Date:  2015-04-29       Impact factor: 3.922

5.  Prostate cancer organoids: a potential new tool for testing drug sensitivity.

Authors:  Ian Vela; Yu Chen
Journal:  Expert Rev Anticancer Ther       Date:  2015-01-20       Impact factor: 4.512

6.  A reproducible scaffold-free 3D organoid model to study neoplastic progression in breast cancer.

Authors:  Sabra I Djomehri; Boris Burman; Maria E Gonzalez; Shuichi Takayama; Celina G Kleer
Journal:  J Cell Commun Signal       Date:  2018-12-04       Impact factor: 5.782

7.  3D Tumor Spheroid Models for In Vitro Therapeutic Screening of Nanoparticles.

Authors:  Simonas Daunys; Agnė Janonienė; Indrė Januškevičienė; Miglė Paškevičiūtė; Vilma Petrikaitė
Journal:  Adv Exp Med Biol       Date:  2021       Impact factor: 2.622

8.  Tumor-mesoporous silica nanoparticle interactions following intraperitoneal delivery for targeting peritoneal metastasis.

Authors:  Derek Hargrove; Brian Liang; Raana Kashfi-Sadabad; Gaurav N Joshi; Laura Gonzalez-Fajardo; Sterling Glass; Michael Jay; Andrew Salner; Xiuling Lu
Journal:  J Control Release       Date:  2020-11-07       Impact factor: 9.776

Review 9.  Emerging Roles of Electrospun Nanofibers in Cancer Research.

Authors:  Shixuan Chen; Sunil Kumar Boda; Surinder K Batra; Xiaoran Li; Jingwei Xie
Journal:  Adv Healthc Mater       Date:  2017-12-06       Impact factor: 9.933

10.  In vitro and in vivo antitumor effects of the VO-chrysin complex on a new three-dimensional osteosarcoma spheroids model and a xenograft tumor in mice.

Authors:  Ignacio E León; Juan F Cadavid-Vargas; Agustina Resasco; Fabricio Maschi; Miguel A Ayala; Cecilia Carbone; Susana B Etcheverry
Journal:  J Biol Inorg Chem       Date:  2016-10-01       Impact factor: 3.358

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.